Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,564 | -2,990 | -1,518 | -3,781 | -2,216 |
| Depreciation Amortization | 612 | 709 | 482 | 80 | 75 |
| Accounts receivable | -135 | 2 | -1 | 1 | -1 |
| Other Working Capital | 1,706 | 177 | -108 | 972 | 629 |
| Other Operating Activity | 967 | 145 | 120 | 1,124 | 421 |
| Operating Cash Flow | $-3,414 | $-1,957 | $-1,026 | $-1,604 | $-1,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -9 | -3 | -110 | -1 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -750 | -750 |
| Other Investing Activity | -6 | -6 | -4 | -800 | -800 |
| Investing Cash Flow | $-41 | $-15 | $-7 | $-910 | $-801 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,310 | 2,310 | 1,480 | 2,425 | 1,858 |
| Debt Repayment | -264 | -264 | -2 | -16 | -22 |
| Common Stock Issued | 9,367 | 4,634 | 84 | 108 | 100 |
| Other Financing Activity | -28 | -28 | 0 | 0 | 0 |
| Financing Cash Flow | $11,385 | $6,652 | $1,562 | $2,517 | $1,937 |
| Beginning Cash Position | 12 | 12 | 12 | 10 | 10 |
| End Cash Position | 7,943 | 4,693 | 541 | 12 | 52 |
| Net Cash Flow | $7,930 | $4,680 | $529 | $3 | $43 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,414 | -1,957 | -1,026 | -1,604 | -1,093 |
| Capital Expenditure | -35 | -9 | -3 | -110 | -1 |
| Free Cash Flow | -3,449 | -1,966 | -1,029 | -1,714 | -1,094 |